刊物主题:Biomedicine Immunology Pharmacology and Toxicology Allergology Dermatology Neurology Rheumatology
出版者:Birkh盲user Basel
ISSN:1420-908X
文摘
Background: The Interleukin-1 (IL-1) signaling component TAK1 binding protein 2 (TAB2) plays a role in activating the NFκB and JNK signaling pathways. Additionally, TAB2 functions in the nucleus as a repressor of NFκB-mediated gene regulation.